Journal
TRENDS IN BIOCHEMICAL SCIENCES
Volume 40, Issue 7, Pages 377-384Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tibs.2015.03.002
Keywords
CDG; disease; glycoprotein; endoplasmic reticulum; Golgi
Categories
Funding
- Swiss National Foundation [310030-149949]
- Swiss National Science Foundation (SNF) [310030_149949] Funding Source: Swiss National Science Foundation (SNF)
Ask authors/readers for more resources
Glycosylation is a ubiquitous modification of lipids and proteins. Despite the essential contribution of glycoconjugates to the viability of all living organisms, diseases of glycosylation in humans have only been identified over the past few decades. The recent development of next-generation DNA sequencing techniques has accelerated the pace of discovery of novel glycosylation defects. The description of multiple mutations across glycosylation pathways not only revealed tremendous diversity in functional impairments, but also pointed to phenotypic similarities, emphasizing the interconnected flow of substrates underlying glycan assembly. The current list of 100 known glycosylation disorders provides an overview of the significance of glycosylation in human development and physiology.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available